Biphenyl scaffold for the design of NMDA-receptor negative modulators: molecular modeling, synthesis, and biological activity.
Dmitry S Karlov, Nadezhda S Temnyakova, Dmitry A Vasilenko, Oleg I Barygin, Mikhail Y Dron, Arseniy S Zhigulin, Elena B Averina, Yuri K Grishin, Vladimir V Grigoriev, Alexey V Gabrel'yan and 7 more
Article in RSC medicinal chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 7 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors at 5 institutions in 1 country.
Dmitry S KarlovSkolkovo Institute of Science and Technology, Skolkovo Innovation Center 143026 Moscow Russian Federation dkar89@gmail.com.ORCID https://orcid.org/0000-0002-7194-1081
Nadezhda S TemnyakovaDepartment of Chemistry, Lomonosov Moscow State University 119991 Moscow Russian Federation.
Dmitry A VasilenkoDepartment of Chemistry, Lomonosov Moscow State University 119991 Moscow Russian Federation.
Oleg I BaryginI. M. Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences 194223 St. Petersburg Russian Federation.
Mikhail Y DronI. M. Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences 194223 St. Petersburg Russian Federation.
Arseniy S ZhigulinI. M. Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences 194223 St. Petersburg Russian Federation.
Petr A PopovSkolkovo Institute of Science and Technology, Skolkovo Innovation Center 143026 Moscow Russian Federation dkar89@gmail.com.ORCID https://orcid.org/0000-0003-3745-7154
Maxim V FedorovSkolkovo Institute of Science and Technology, Skolkovo Innovation Center 143026 Moscow Russian Federation dkar89@gmail.com.
Lomonosov Moscow State University · RUSkolkovo Institute of Science and Technology · RUInstitute of Evolutionary Physiology and Biochemistry · RUInstitute of Higher Nervous Activity and Neurophysiology · RUInstitute of Physiologically Active Compounds · RU
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Biphenyl scaffold for the design of NMDA-receptor negative modulators: molecular modeling, synthesis, and biological activity. · full record | OpenQuestion